Christoph B. Olivier/LinkedIn
Mar 8, 2026, 10:57
Christoph B. Olivier: Celebrating the Transformative Impact of Women in Research
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared on LinkedIn:
”The impact of Women in research
At the Antithrombotic Research Group, International Women’s Day is an opportunity to reaffirm our commitment to a field where equity prevail.
We are proud to be an example of equality and development.
Today, we celebrate the fundamental role of our researchers, whose technical and analytical expertise is redefining global health standards.
As a group, we hold one core premise: Women are not just a part of history; they change history.
Our most sincere congratulations to all on this International Women’s Day.
Learn more about our team and our mission”
Stay updated with Hemostasis Today.
-
Sep 6, 2026, 05:58Mohamed F Doheim: ‘Stroke as a Symphony’ – Rethinking Decision-Making in Acute Ischemic Stroke
-
Sep 6, 2026, 05:26Yousef Hindi: Unprovoked Left Renal Vein Thrombosis and Severe IDA – Long-Term Resolution and Dual-Energy CT Findings
-
Sep 6, 2026, 05:18Robert Brown: Standardizing Amniotic Fluid Embolism Diagnosis – SMFM and AFE Foundation Criteria
-
Sep 6, 2026, 04:45Mohammed Al Kanan: Early Identification of VTE Risk in Lung Cancer Patients
-
Sep 6, 2026, 04:38M. Ibrahim Siddique: Does Routine Triple Therapy Pay Off After Anterior STEMI?
-
Sep 6, 2026, 04:29Sandra Revill Tremulis: The Lp(a)HORIZON Topline Results Raise Important Questions Beyond Simply ‘Does Lowering Lp(a) Work?’
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX